Compare SLN & GCBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLN | GCBC |
|---|---|---|
| Founded | 1994 | 1889 |
| Country | United Kingdom | United States |
| Employees | 116 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 236.2M | 374.8M |
| IPO Year | N/A | 1998 |
| Metric | SLN | GCBC |
|---|---|---|
| Price | $5.75 | $22.35 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $39.67 | N/A |
| AVG Volume (30 Days) | ★ 168.0K | 8.7K |
| Earning Date | 01-01-0001 | 04-22-2026 |
| Dividend Yield | N/A | ★ 1.76% |
| EPS Growth | N/A | ★ 26.21 |
| EPS | N/A | ★ 1.13 |
| Revenue | N/A | ★ $4,117,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $20.04 |
| Revenue Growth | N/A | ★ 11.06 |
| 52 Week Low | $1.97 | $20.00 |
| 52 Week High | $7.78 | $26.50 |
| Indicator | SLN | GCBC |
|---|---|---|
| Relative Strength Index (RSI) | 59.50 | 44.17 |
| Support Level | $5.07 | $21.39 |
| Resistance Level | $6.10 | $23.35 |
| Average True Range (ATR) | 0.49 | 0.92 |
| MACD | 0.16 | -0.13 |
| Stochastic Oscillator | 65.37 | 24.18 |
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.
Greene County Bancorp Inc is a holding firm. Its primary business involves overseeing and directing the business of The Bank of Greene County and monitoring its cash position. Through its directly and indirectly owned subsidiaries, the company engages in attracting retail deposits, along with funds generated from operations and borrowings, predominantly in one to four-family residential mortgage loans, commercial real estate mortgage loans, consumer loans, home equity loans, and commercial business loans. It also serves local municipalities' banking needs and operates a real estate investment trust.